Estrogen treatment prevents gray matter atrophy in experimental autoimmune encephalomyelitis

Estriol Generates Tolerogenic Dendritic Cells In Vivo That Protect against Autoimmunity

(2011) T. L. Papenfuss et al.   JOURNAL OF IMMUNOLOGY

Neuroprotection mediated through estrogen receptor-  in astrocytes

(2011) R. D. Spence et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Oestrogen receptor β ligand: a novel treatment to enhance endogenous functional remyelination

(2010) Daniel K. Crawford et al.   BRAIN

Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis

(2010) I. J. van den Elskamp et al.   NEURORADIOLOGY

Neuroprotection in multiple sclerosis: A therapeutic challenge for the next decade

(2010) Anneke Van der Walt et al.   PHARMACOLOGY & THERAPEUTICS

Magnetic resonance evidence of cerebellar cortical pathology in multiple sclerosis

(2009) M. Calabrese et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Axial Diffusivity Is the Primary Correlate of Axonal Injury in the Experimental Autoimmune Encephalomyelitis Spinal Cord: A Quantitative Pixelwise Analysis

(2009) M. D. Budde et al.   JOURNAL OF NEUROSCIENCE

Neuroprotective and anti-inflammatory effects of estrogen receptor ligand treatment in mice

(2009) Seema Tiwari-Woodruff et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERα)

(2009) Stefan M Gold et al.   LABORATORY INVESTIGATION

Purkinje cell loss in experimental autoimmune encephalomyelitis

(2009) Allan MacKenzie-Graham et al.   NEUROIMAGE

Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis

(2008) M. P. Amato et al.   NEUROLOGY